Delivery Order SPE2DB22D3102-SPE2DB25FL2VR
- Not listed
- The Defense Logistics Agency awarded a $3,128.12 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,648.80 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price contract, which is part of a larger Indefinite Delivery Contract vehicle, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The...
- The Defense Logistics Agency awarded a $1,351.35 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed price, competitively awarded contract involves the supply of the diabetes medication from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 3 mg/0.5 ml pens valued at $5,712.11 with an ultimate completion date of July 21, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a $1,263.40 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 3 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract represents a single delivery order with a completion deadline of September 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among qualified vendors capable...
- The Defense Logistics Agency awarded a delivery order valued at $6,631.17 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on April 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order with an ultimate completion date of April 25, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations....
- The Defense Logistics Agency awarded a delivery order valued at $15,752.63 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens (0.5 ml units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 25, 2025, issued on August 22, 2025. AmerisourceBergen will fulfill this order from its corporate office in Conshohocken, Pennsylvania, where the company is headquartered as a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,915.55 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens. This firm fixed-price, competitively awarded contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $6,354.48 under a firm fixed-price contract. This non-set-aside delivery order, which is due for completion by July 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2VRDelivery Order
The Defense Logistics Agency awarded a $3,603.60 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on September 5, 2025, with completion expected by September 8, 2025. This non-set-aside, firm fixed-price contract represents a routine pharmaceutical delivery under the company's broader federal medical supply portfolio. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and distribution hub. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a critical pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with consistent delivery of diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/5/25 |